Pharmaceuticals and Healthcare Reports Focal Segmental Glomerulosclerosis (FSGS) Market

Focal Segmental Glomerulosclerosis (FSGS) Market Size, Analysis and Pipeline Review Report 2016 “Focal Segmental glomerulosclerosis is a rare disease that attacks the kidney's filtering units (glomeruli) causing serious scarring which leads to permanent kidney damage and even failure.” Summary The Report provides an overview of the Focal Segmental Glomerulosclerosis (Genito Urinary System And Sex Hormones) pipeline landscape. Complete Report Available @ http://www.radiantinsights.com/research/focal- segmental-glomerulosclerosis-fsgs-pipeline-review-h2-2016 Focal Segmental glomerulosclerosis is a rare disease that attacks the kidney's filtering units (glomeruli) causing serious scarring which leads to permanent kidney damage and even failure. Symptoms include proteinuria, edema, high cholesterol, high blood pressure and poor appetite. Risk factors include infection, obesity, sickle cell disease and reflux nephropathy. Treatment includes antibiotics, vitamin D supplements, and immunosuppressive drugs. Report Highlights Radiant Insights's Pharmaceutical and Healthcare latest pipeline guide Focal Segmental Glomerulosclerosis - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Focal Segmental Glomerulosclerosis (Genito Urinary System Follow Us: